Sources: Mayo Clinic, MRFR Analysis
Key players of Global Lactate dehydrogenase test Market:
Key players profiled in the report are LifeSpan BioSciences, Aviva Systems Biology, Accurex Biomedical Pvt. Ltd., Thermo Fisher Scientific, Bioo Scientific Corporation, Quest Diagnostics, Abcam plc., Randox Laboratories Ltd., Sigma-Aldrich Co. LLC., Merck KGaA and others.
The global lactate dehydrogenase test market is segmented on the basis of type, indications, equipment, and end users. Based on type, the market has been segmented as lactate dehydrogenase 1 (LD1), lactate dehydrogenase 2 (LD2), lactate dehydrogenase 3 (LD3), lactate dehydrogenase 4 (LD4), and lactate dehydrogenase 5 (LD5). Based on the indications, the market has been segmented as cerebrovascular diseases, liver diseases, blood disorders, muscle dystrophy and fatigue, necrosis, infections, substance abuse, and others. Based on the equipment, the market has been segmented as instruments (spectroscope, centrifuge, others), consumables and others. Based on the end users, the market has been segmented as hospitals and clinics, diagnostic laboratories, academic and research and others.
Figure 1 Global Lactate dehydrogenase test Market, by Indications, 2016 (% Market Share)
US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global lactate dehydrogenase test. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration. The report for Global Lactate dehydrogenase test Market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
|Market Size||2023: $ 6.4 Billion|
|Forecast Units||Value (USD Billion)|
|Report Coverage||Revenue Forecast, Competitive Landscape, Growth Factors, and Trends|
|Segments Covered||Type, Indications, Equipment and End Users|
|Geographies Covered||North America, Europe, Asia-Pacific, and Rest of the World (RoW)|
|Key Vendors||LifeSpan BioSciences, Aviva Systems Biology, Accurex Biomedical Pvt. Ltd., Thermo Fisher Scientific, Bioo Scientific Corporation, Quest Diagnostics, Abcam plc., Randox Laboratories Ltd., Sigma-Aldrich Co. LLC., Merck KGaA|
|Key Market Opportunities||Favorable reimbursement scenario and greater expenditure on healthcare In US Market|
|Key Market Drivers||
Frequently Asked Questions (FAQ) :
Lactate dehydrogenase test market size can touch 6.4 billion by 2023.
Lactate dehydrogenase test market is set to accumulate revenues at 8.8% CAGR from 2017 to 2023.
Rising incidence of cardiovascular diseases is the major growth driver of the global lactate dehydrogenase test market.
The U.S. can drive global demand owing to the uptick witnessed in adoption of latest diagnostic tests and favorable reimbursement policies.
Abcam plc., Aviva Systems Biology, Thermo Fisher Scientific, LifeSpan BioSciences, Accurex Biomedical Pvt. Ltd., Merck KGaA, Quest Diagnostics, Bioo Scientific Corporation, Sigma-Aldrich Co. LLC., and Randox Laboratories Ltd. are major players of the global lactate dehydrogenase test market.